Changchun Bcht Biotechnology Co.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Changchun Bcht Biotechnology Co. - overview
Established
2004
Location
Changchun, -, China
Primary Industry
Biotechnology
About
Based in Changchun, China and established in 2004, Changchun Bcht Biotechnology Co. is a biotech company that focuses on the research and development of drugs. In 2007, the company acquired Jilin Maifeng Biopharmaceutical Industry. In 2021, the company was listed on the Shanghai Stock Exchange.
The company engages in the research and development of biological vaccines and genetic engineering drugs. Its main products include live attenuated varicella vaccine and human rabies vaccine, etc.
Current Investors
Changchun High-Tech Venture Capital Group
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.